Literature DB >> 7357545

Transport of melphalan by sensitive and resistant L1210 cells.

W R Redwood, M Colvin.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7357545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  17 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Development of alkylating agent-resistant human tumor cell lines.

Authors:  B A Teicher; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Alkylating agent resistance: in vitro studies with human cell lines.

Authors:  E Frei; C A Cucchi; A Rosowsky; R Tantravahi; S Bernal; T J Ervin; R M Ruprecht; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 5.  Oral alkylating agents for breast cancer therapy.

Authors:  J A O'Shaughnessy
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.

Authors:  M J Yagi; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Authors:  Q Dong; N Bullock; F Ali-Osman; O M Colvin; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

8.  Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Authors:  M J Yagi; M Zanjani; J F Holland; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.

Authors:  W R Waud; J Plowman; S D Harrison; D J Dykes; W K Anderson; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine.

Authors:  V Gupta; J P Jani; S Jacobs; M Levitt; L Fields; S Awasthi; B H Xu; M Sreevardhan; Y C Awasthi; S V Singh
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.